Infliximab-Dyyb

Common brands: Inflectra, Prednisone, Prednisone Delayed Release, Prednisone Tablets, Usp, 10 Mg, Prednisone Tablets, Usp, 20 Mg

Top reporter: Pfizer Laboratories Div Pfizer Inc

Tumor Necrosis Factor Blocker [EPC]Corticosteroid [EPC]Folate Analog Metabolic Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Aminosalicylate [EPC]
28,176
Total Reports
21,795
Serious Reports
678
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.41%)

Patient Demographics

Male
1,247
Female
1,837

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Infliximab-Dyyb.

# Reaction Reports % of Total
1 OFF LABEL USE 14,843
15.6%
2 CONDITION AGGRAVATED 10,590
11.1%
3 INTENTIONAL PRODUCT USE ISSUE 8,076
8.5%
4 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6,227
6.6%
5 ARTHRALGIA 4,827
5.1%
6 DRUG INEFFECTIVE 3,548
3.7%
7 FATIGUE 3,319
3.5%
8 WEIGHT INCREASED 2,946
3.1%
9 MALAISE 2,877
3.0%
10 WEIGHT DECREASED 2,819
3.0%
11 BLOOD PRESSURE INCREASED 2,366
2.5%
12 HEADACHE 2,357
2.5%
13 COVID-19 2,341
2.5%
14 NAUSEA 2,320
2.4%
15 PAIN 2,262
2.4%
16 BLOOD PRESSURE FLUCTUATION 1,946
2.0%
17 NASOPHARYNGITIS 1,924
2.0%
18 THERAPEUTIC RESPONSE SHORTENED 1,875
2.0%
19 COUGH 1,825
1.9%
20 PYREXIA 1,698
1.8%
21 HEART RATE DECREASED 1,555
1.6%
22 INCORRECT DOSE ADMINISTERED 1,550
1.6%
23 ABDOMINAL PAIN 1,484
1.6%
24 DIZZINESS 1,459
1.5%
25 PRURITUS 1,437
1.5%
26 DIARRHOEA 1,436
1.5%
27 DYSPNOEA 1,408
1.5%
28 VOMITING 1,285
1.4%
29 DRUG LEVEL DECREASED 1,237
1.3%
30 OROPHARYNGEAL PAIN 1,197
1.3%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.